The Outcomes and Surgical Nuances of Minimally Invasive Parotid Surgery for Pleomorphic Adenoma

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2023 Nov 17

PMID 37974711

Authors

Kalyana Sundaram Chidambaram

Manjul Muraleedharan

Amit Keshri

Sabaratnam Mayilvaganan

Nazrin Hameed

Mohd Aqib

Arushi Kumar

Ravi Sankar Manogaran

Raj Kumar

Affiliations

Soon will be listed here.

Abstract

Benign parotid tumors follow an indolent course and present as slow-growing painless swelling in the pre-and-infra-auricular areas. The treatment of choice is surgery. Though the gold standard technique is Superficial Parotidectomy, Extracapsular Dissection (ECD) is an alternative option with the same outcome and decreased complications. This study discusses our experience with extracapsular dissection and the surgical nuances for better results. A retrospective study of histologically confirmed cases of pleomorphic adenoma of the parotid gland, who underwent Extracapsular dissection between September 2019 and March 2023, was done. The demographic details, clinical characteristics, and outcomes were evaluated. There were 33 patients, including 16 females and 17 males, with a mean age of 32.75 years. All cases presented as slow-growing painless swelling for a mean duration of 5 years. Most of the tumors (94%) were of size between 2 and 4 cm, with few tumors more than 4 cm. All underwent extracapsular dissection with complete excision. There was only one complication (seroma) and no incidence of facial palsy in our experience with ECD. The goal of a benign parotid surgery is the complete removal of the tumor with minimum complications, which could be achieved with ECD, which has good tumor clearance and lesser rates of complications with good cosmesis. Thus, this minimally invasive parotid surgery could be a worthwhile option in properly selected cases.

References

Martis C . Parotid benign tumors: comments on surgical treatment of 263 cases. Int J Oral Surg. 1983; 12(4):211-20. DOI: 10.1016/s0300-9785(83)80045-3. View

Heller K, ATTIE J . Treatment of Warthin's tumor by enucleation. Am J Surg. 1988; 156(4):294-6. DOI: 10.1016/s0002-9610(88)80295-2. View

Quer M, Vander Poorten V, Takes R, Silver C, Boedeker C, de Bree R . Surgical options in benign parotid tumors: a proposal for classification. Eur Arch Otorhinolaryngol. 2017; 274(11):3825-3836. DOI: 10.1007/s00405-017-4650-4. View

Xie S, Wang K, Xu H, Hua R, Li T, Shan X . PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients. Medicine (Baltimore). 2015; 94(34):e1237. PMC: 4602923. DOI: 10.1097/MD.0000000000001237. View

Ghosh S, Panarese A, Bull P, Lee J . Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions. Clin Otolaryngol Allied Sci. 2003; 28(3):262-6. DOI: 10.1046/j.1365-2273.2003.00704.x. View

Terrell J, Kileny P, Yian C, Esclamado R, Bradford C, Pillsbury M . Clinical outcome of continuous facial nerve monitoring during primary parotidectomy. Arch Otolaryngol Head Neck Surg. 1997; 123(10):1081-7. DOI: 10.1001/archotol.1997.01900100055008. View

Albergotti W, Nguyen S, Zenk J, Gillespie M . Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope. 2012; 122(9):1954-60. DOI: 10.1002/lary.23396. View

Skalova A, Kaspirkova J, Andrle P, Hosticka L, Vanecek T . Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Cesk Patol. 2013; 49(2):72-5. View

Kato M, Erkul E, Nguyen S, Day T, Hornig J, Lentsch E . Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017; 143(11):1092-1097. PMC: 5710353. DOI: 10.1001/jamaoto.2017.1618. View

10.

Wong W, Shetty S . Classification of parotidectomy: a proposed modification to the European Salivary Gland Society classification system. Eur Arch Otorhinolaryngol. 2017; 274(8):3175-3181. DOI: 10.1007/s00405-017-4581-0. View

11.

Bar B, Mantsopoulos K, Iro H . Paradigm shift in surgery for benign parotid tumors: 19 years of experience with almost 3000 cases. Laryngoscope. 2019; 130(8):1941-1946. DOI: 10.1002/lary.28454. View

12.

Chegini S, Sassoon I, McGurk M . Extracapsular dissection (ECD) and extended ECD: description of the technique and outcome of treatment. Br J Oral Maxillofac Surg. 2022; 60(8):1062-1067. DOI: 10.1016/j.bjoms.2021.10.022. View

13.

PATEY D, Thackray A . The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958; 45(193):477-87. DOI: 10.1002/bjs.18004519314. View

14.

Stea G . Conservative surgical treatment of mixed tumours of the parotid gland. J Maxillofac Surg. 1975; 3(2):135-7. DOI: 10.1016/s0301-0503(75)80032-4. View

15.

Bradley P, McGurk M . Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg. 2012; 51(5):399-403. DOI: 10.1016/j.bjoms.2012.10.002. View

16.

GRAGE T, LOBER P, SHAHON D . Benign tumors of the major salivary glands. Surgery. 1961; 50:625-33. View

17.

Hafed L, Farag H, Shaker O, El-Rouby D . Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol. 2012; 57(9):1194-9. DOI: 10.1016/j.archoralbio.2012.03.009. View

18.

Dulguerov P, Marchal F, Lehmann W . Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. 1999; 109(5):754-62. DOI: 10.1097/00005537-199905000-00014. View

19.

Eveson J, CAWSON R . Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985; 146(1):51-8. DOI: 10.1002/path.1711460106. View

20.

PERZIK S . End results in parotid tumors. Calif Med. 1957; 86(4):223-8. PMC: 1511864. View